City

Baltimore (1)

Boston (1)

Cleveland (1)

New York (1)

Tampa (1)

Villejuif (1)

Condition

Myelomonocytic Leukemia (2)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

n/a (1)

phase 1/phase 2 (1)

Sponsor

Gustave Roussy, Cancer Campus, Grand Paris (1)

H. Lee Moffitt Cancer Center and Research Institute (1)

Collaborator

Incyte Corporation (1)

Intervention

deuterium glucose (1)

ruxolitinib (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

Other (2)

Study Type

Interventional (2)

myelomonocytic leukemia

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Myelomonocytic Leukemia Trial in United States (Ruxolitinib)

Completed

Myelomonocytic Leukemia

Ruxolitinib

Tampa, Florida
+5 more

Sep 9, 2022

Myelomonocytic Leukemia Trial in Villejuif (Deuterium Glucose)

Recruiting

Myelomonocytic Leukemia

Deuterium Glucose

Villejuif, Val De Marne, France

Gustave Roussy

Feb 26, 2021